Central Pharmaceutical Affairs Review Committee to implement drug reclassification plan
Published: 2011-06-08 06:58:00
Updated: 2011-06-08 06:58:00
The Ministry of Health and Welfare said that the Central Pharmaceutical Affairs Review Committee, which is under the umbrella of the Korea Food and Drug Administration, will be mainly responsible for pushing up with an OTC switching plan of prescription drugs.
In a briefing, a health ministry ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
